AMLN Related
-
Bristol-Myers Squibb (BMY) Reports Waiting Period to Acquire Amylin Pharmaceuticals (AMLN) Expired
-
Bristol-Myers Squibb (BMY) Commences $31/Share Cash Tender for Amylin (AMLN)
-
Stocks with implied volatility movement; AMLN CVS
-
Stocks with implied volatility below IV index mean; AMLN LNCR
-
Top 10 News Items 7/2-7/6: Private Sector Showed Slowest Pace of Job Growth in 10 Months; Central Banks React; Mergers Get Serious on Monday
-
Stocks with implied volatility below IV index mean; AMLN LNCR
-
Morgan Stanley Upgrades Amylin Pharmaceuticals (AMLN) to Equalweight
-
Market Wrap: US Manufacturing Hits the Skids; Apple Settles 'iPad' Suit; Merger Monday!
-
Barclays on AstraZeneca (AZN): Acquisition of AMLN Makes Strategic Sense but High Price Tag
-
S&P Biotech EFT (XBI) Pops on Amylin (AMLN) Buyout News
-
Notable Mergers and Acquisitions of the Day 07/02: (BMY)/(AMLN) (MU) (IM)/(CELL) (DELL)/(QSFT)
-
Pre-Open Winners 7/2: (CELL) (LNCR) (AMLN) (more...)
-
BMO Capital Downgrades Amylin Pharmaceuticals (AMLN) to Market Perform
-
Amylin (AMLN) volatility low into Bristol-Myers paying $5.3B
-
Bristol-Myers Squibb (BMY) Acquires Amylin (AMLN) for $31/Share
-
Jefferies Says FDA Request from Amylin (AMLN) Will Not Impact Acquisition Potential
-
Amylin (AMLN) Wants a Buyout Price At Least in the Low-to-Mid $30s - Jefferies
-
Amylin (AMLN) Says SYMLIN + Insulin Gives Better Blood Glicose Measurement Results in Type 1, 2 Diabetes
-
Amylin (AMLN), Alkermes (ALKS) Say BYDUREON Achieved Statistically Significant Glycemic Control Results in Type 2 Diabetes
-
Amylin Pharma (AMLN), Alkermes (ALKS) Reports Encouraging A1C Data from BYDUREON in Type 2 Diabetes
-
Amylin Pharma (AMLN) Says BYETTA Glycemic Control Results Better than Amaryl in Type 2 Diabetes
-
Pre-Open Movers 6/5: (OPXT) (WPRT) (GNOM) Higher; (LLNW) (AKAM) (LVLT) Lower (more...)
-
Amylin (AMLN) Bidding Intensifies; Sale Expected in July
-
Shares of Amylin (AMLN) on the move as Reuters reporting first round bids over $25/share
-
Notable Analyst Rating Changes 05/31: (JBLU) (ZNGA) (TEF) Upgraded; (CLF) (AMLN) (CHRW) Downgraded
-
Baird Downgrades Amylin Pharmaceuticals (AMLN) to Neutral
-
Stocks with implied volatility below IV index mean; HGSI AMLN
-
Amylin Pharmaceuticals (AMLN) Sees Late Day Pressure
-
Amylin (AMLN) Shares Jump as Bids Due Today, Sanofi (SNY), Merck (MRK) Said to Make First-Round Bids
-
Carl Icahn Releases Q1 13F
-
Pre-Open Movers 5/15: (GRPN) (DKS) (ZNGA) Higher; (SUMR) (AVP) (SKS) Lower (more...)
-
Amylin (AMLN) Attracting a Host of Other Suitors, Shares Rise
-
Stocks with implied volatility movement; AMLN GT
-
Stocks with implied volatility below IV index mean; AMLN HGSI
-
Amylin Pharmaceuticals (AMLN) Posts Narrower than Expected Q1 Loss of 23c/Share
-
Icahn Says Affiliates Voluntarily Dismiss Suit Against Amylin (AMLN)
-
Amarin (AMRN) Shares Rise Following M&A Chatter; Other Targets Mentioned (AMLN) (FRX)
-
Notable 52-Week Highs and Lows of the Day 04/23: (EAT) (AMLN) High; (NOK) (FSLR) Low
-
Unusual 11 Mid-Day Movers 04/23: (RDEA) (KERX) (CEDC) Higher; (OTT) (ACHN) (NABI) Lower
-
Morning Movers 04/23: (RDEA) (KERX) (CEDC) (AMLN) Higher; (OTT) (NABI) (ACHN) Lower
-
Pre-Open Movers 4/23: (RDEA) (CEDC) (KERX) Higher; (ACHN) (K) (WMT) Lower (more...)
-
Amylin (AMLN) Shares Pop on New M&A Chatter (BMY) (AZN)
-
Amylin (AMLN) Shares Dip Ahead of Close
-
Canaccord Genuity on Biotechnology: Q1 Earnings Preview - What To Expect
-
Stocks with implied volatility below IV index mean; MAT AMLN
-
Stocks with implied volatility below IV index mean; MAT AMLN
-
Stocks with implied volatility below IV index mean; MAT AMLN
-
Stock with implied volatility below IV index mean; AMLN
-
Icahn Files Suit Against Amylin (AMLN), Seeks Extension of Nomination Deadline
-
Amylin (AMLN) Shares Rally Into Close as WSJ Says Bristol (BMY) Still Looking at Co.
Back to AMLN Stock Lookup
